Neurology
Conference Coverage
Strength of fibromyalgia as marker for seizures questioned
HOUSTON – The specificity of fibromyalgia as a marker for psychogenic nonepileptic seizures is less reliable than previously described, results...
Conference Coverage
One in three older adults with epilepsy has poor adherence to antiepileptics
HOUSTON
Conference Coverage
Aspirin use linked to increased ICH in trauma patients
WAIKOLOA, HAWAII – Among a group of anticoagulated trauma patients, those on aspirin had the highest rate and risk of intracranial hemorrhage,...
Conference Coverage
Ketogenic diet, with variations, can help adult epilepsy
HOUSTON
Conference Coverage
Dementia prevalence increased in heart failure patients
NEW ORLEANS - Elderly patients with heart failure had a significantly increased prevalence of both dementia and mild cognitive impairment,...
From the Journals
Nomogram predicts conversion of first demyelinating event to definite MS
Baseline and follow-up data from a prospective, multinational cohort of more than 3,000 patients with clinically isolated events allowed...
Conference Coverage
Few drug-resistant epilepsy patients recruitable for trials of new AEDs
HOUSTON – Fewer than 8% of adult patients with drug-resistant epilepsy would have been recruitable for recent phase II and III trials of new...
Conference Coverage
Wrist-worn system detected convulsive seizures in home setting
HOUSTON – A wrist-worn device and smartphone-based alert system worn by a patient outside of the epilepsy monitoring unit for 3 months effectively...
Feature
Legislators commit to bipartisan support of Alzheimer’s funding
WASHINGTON - The nation's political sea-change won't wash Alzheimer's disease research funding offtrack, two legislators vowed at a Washington...
Feature
Antiamyloid solanezumab fails to slow decline in mild Alzheimer’s
Solanezumab, a monoclonal antibody that targets amyloid plaques, did not slow cognitive decline in patients with mild Alzheimer’s disease.
Conference Coverage
PPIs may boost ischemic stroke risk
NEW ORLEANS – Use of proton pump inhibitors appears to be an independent risk factor for first ischemic stroke.